Logo image of CLX

CLOROX COMPANY (CLX) Stock Analyst Earnings Estimates

NYSE:CLX - New York Stock Exchange, Inc. - US1890541097 - Common Stock - Currency: USD

151.03  +2.66 (+1.79%)

After market: 151.03 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CLX revenue by date.CLX revenue by date.
7.107B
-3.19%
7.389B
3.97%
7.093B
-4.01%
7.205B
1.58%
7.296B
1.26%
7.504B
2.85%
7.848B
4.58%
8.248B
5.10%
8.561B
3.79%
8.895B
3.90%
9.247B
3.96%
EBITDA
YoY % growth
CLX ebitda by date.CLX ebitda by date.
936M
-34.50%
1.048B
11.97%
1.156B
10.31%
1.45B
25.43%
1.51B
4.14%
1.592B
5.43%
1.695B
6.47%
1.777B
4.84%
1.852B
4.22%
1.939B
4.70%
2.025B
4.44%
EBIT
YoY % growth
CLX ebit by date.CLX ebit by date.
712M
-41.54%
812M
14.04%
921M
13.42%
1.236B
34.20%
1.281B
3.64%
1.369B
6.87%
1.441B
5.26%
1.518B
5.34%
1.59B
4.74%
1.667B
4.84%
1.742B
4.50%
Operating Margin
CLX operating margin by date.CLX operating margin by date.
10.02%10.99%12.98%17.15%17.56%18.24%18.36%18.40%18.57%18.74%18.84%
EPS
YoY % growth
CLX eps by date.CLX eps by date.
4.11
-47.44%
5.09
23.84%
6.18
21.41%
7.27
17.56%
7.35
1.23%
7.79
5.89%
8.43
8.21%
9.06
7.51%
9.59
5.85%
10.35
7.95%
11.10
7.22%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.61
-5.58%
2.23
22.76%
1.68
-9.85%
1.67
7.46%
1.81
11.84%
2.25
0.50%
1.78
6.01%
1.77
6.12%
1.87
3.76%
2.48
10.65%
Revenue
Q2Q % growth
1.762B
-2.87%
1.975B
3.78%
1.741B
-1.19%
1.754B
4.03%
1.826B
3.63%
2.019B
2.23%
1.815B
4.25%
1.815B
3.48%
1.877B
2.79%
2.107B
4.36%
EBITDA
Q2Q % growth
340.96M
-17.64%
445.63M
-13.64%
355.16M
-1.34%
343.66M
0.78%
367.31M
7.73%
448.06M
0.55%
371.15M
4.50%
356.15M
3.63%
385.66M
5.00%
468.12M
4.48%
EBIT
Q2Q % growth
284.48M
19.53%
385.72M
37.27%
287.2M
-6.14%
295.58M
26.32%
312.62M
9.89%
387.16M
0.37%
310.63M
8.16%
296.32M
0.25%
318.63M
1.92%
405.96M
4.86%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.55
-28.24%
1.420.139.12%
Q1 2025
Q2Q % growth
1.86
279.59%
1.410.4532.02%
Q4 2024
Q2Q % growth
1.82
8.98%
1.580.2415.42%
Q3 2024
Q2Q % growth
1.71
13.25%
1.380.3323.77%
Q2 2024
Q2Q % growth
2.16
120.41%
1.111.0594.70%
Q1 2024
Q2Q % growth
0.49
-47.31%
-0.220.71320.59%
Q4 2023
Q2Q % growth
1.67
79.57%
1.200.4739.73%
Q3 2023
Q2Q % growth
1.51
15.27%
1.240.2722.24%
Q2 2023
Q2Q % growth
0.98
48.48%
0.650.3349.71%
Q1 2023
Q2Q % growth
0.93
-23.14%
0.750.1823.91%
Q4 2022
Q2Q % growth
0.93
-2.11%
0.94-0.01-0.93%
Q3 2022
Q2Q % growth
1.31
-19.14%
0.980.3333.25%
Q2 2022
Q2Q % growth
0.66
-67.49%
0.85-0.19-22.45%
Q1 2022
Q2Q % growth
1.21
-62.42%
1.040.1716.09%
Q4 2021
Q2Q % growth
0.95
-60.58%
1.37-0.42-30.43%
Q3 2021
Q2Q % growth
1.62
-14.29%
1.490.138.50%
Q2 2021
Q2Q % growth
2.03
39.04%
1.800.2312.65%
Q1 2021
Q2Q % growth
3.22
102.52%
2.350.8737.29%
Q4 2020
Q2Q % growth
2.41
28.19%
2.010.4019.66%
Q3 2020
Q2Q % growth
1.89
31.25%
1.680.2112.24%
Q2 2020
Q2Q % growth
1.46
4.29%
1.330.1310.05%
Q1 2020
Q2Q % growth
1.59
-1.85%
1.560.032.14%
Q4 2019
Q2Q % growth
1.88 1.850.031.65%
Q3 2019
Q2Q % growth
1.44 1.47-0.03-1.73%
Q2 2019
Q2Q % growth
1.40 1.320.086.46%
Q1 2019
Q2Q % growth
1.62 1.600.021.48%
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.686B
-15.28%
1.643B43M2.62%
Q1 2025
Q2Q % growth
1.762B
27.13%
1.662B100M6.02%
Q4 2024
Q2Q % growth
1.903B
-5.75%
1.971B-68M-3.45%
Q3 2024
Q2Q % growth
1.814B
-5.27%
1.888B-74M-3.92%
Q2 2024
Q2Q % growth
1.99B
16.03%
1.822B168M9.22%
Q1 2024
Q2Q % growth
1.386B
-20.34%
1.32B66M5.00%
Q4 2023
Q2Q % growth
2.019B
12.10%
1.895B124M6.54%
Q3 2023
Q2Q % growth
1.915B
5.86%
1.836B79M4.30%
Q2 2023
Q2Q % growth
1.715B
1.42%
1.674B41M2.45%
Q1 2023
Q2Q % growth
1.74B
-3.65%
1.71B30M1.75%
Q4 2022
Q2Q % growth
1.801B
-0.06%
1.879B-78M-4.15%
Q3 2022
Q2Q % growth
1.809B
1.57%
1.812B-3M-0.17%
Q2 2022
Q2Q % growth
1.691B
-8.20%
1.681B10M0.59%
Q1 2022
Q2Q % growth
1.806B
-5.74%
1.714B92M5.37%
Q4 2021
Q2Q % growth
1.802B
-9.13%
1.94B-138M-7.11%
Q3 2021
Q2Q % growth
1.781B
-0.11%
1.885B-104M-5.52%
Q2 2021
Q2Q % growth
1.842B
27.12%
1.767B75M4.24%
Q1 2021
Q2Q % growth
1.916B
27.22%
1.772B144M8.13%
Q4 2020
Q2Q % growth
1.983B
21.88%
1.893B90M4.75%
Q3 2020
Q2Q % growth
1.783B
14.96%
1.727B56M3.24%
Q2 2020
Q2Q % growth
1.449B
-1.63%
1.445B4M0.28%
Q1 2020
Q2Q % growth
1.506B
-3.65%
1.527B-21M-1.38%
Q4 2019
Q2Q % growth
1.627B 1.696B-69M-4.07%
Q3 2019
Q2Q % growth
1.551B 1.585B-34M-2.15%
Q2 2019
Q2Q % growth
1.473B 1.488B-15M-1.01%
Q1 2019
Q2Q % growth
1.563B 1.551B12M0.77%
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.72% -2.99% 5.09% 5.02%
Revenue-1.23% -1.4% 1.18% 1.09%